{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:22:28Z","timestamp":1787840548618,"version":"build-2784847793"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autoimmune myasthenia gravis (MG) is sometimes associated with thymic abnormalities. Thymectomy is performed in cases of MG with a thymoma or general MG that is resistant to medical therapy. The aims and objectives of the study are to assess the survivability and response to plasma exchange in patients planned for thymectomy in unstable disease activity status of MG. Plasma exchange is indicated before and after thymectomy in unstable disease activity status. Here, we are presenting case summary of five patients undergoing plasma exchange for unstable disease activity status. The outcome was poor in patients having Masoka staging III and Iva, respectively. The survival rate was 60% during an unstable state of MG with thymoma in our study.<\/jats:p>","DOI":"10.4103\/ajts.ajts_110_22","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T15:02:12Z","timestamp":1760799732000},"page":"396-398","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Role of therapeutic plasma exchange in myasthenia gravis with thymoma: A case series"],"prefix":"10.4103","volume":"19","author":[{"given":"Rashmi","family":"Parashar","sequence":"first","affiliation":[{"name":"Department of Immunohematology and Transfusion Medicine, SMS Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Bundas","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Transfusion Medicine, SMS Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Transfusion Medicine, SMS Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"R1-20251022","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ageing\/afj001","article-title":"Myasthenia gravis \u2013A rare presentation with tongue atrophy and fasciculation","volume":"35","author":"Burch","year":"2006","journal-title":"Age Ageing"},{"key":"R2-20251022","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.amjmed.2014.05.028","article-title":"Myasthenia gravis presenting with dysphagia in an elderly male:A case report","volume":"127","author":"Breen","year":"2014","journal-title":"Am J Med"},{"key":"R4-20251022","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"R5-20251022","first-page":"M597","article-title":"A simple and accurate method for prescribing plasma exchange","volume":"36","author":"Kaplan","year":"1990","journal-title":"ASAIO Trans"},{"key":"R6-20251022","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013Evidence-Based approach from the writing committee of the American society for apheresis:The eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"R7-20251022","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.45.2.338","article-title":"Treatment of myasthenia gravis by immunoadsorption of plasma","volume":"45","author":"Grob","year":"1995","journal-title":"Neurology"},{"key":"R8-20251022","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis:Executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"R9-20251022","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/mus.21924","article-title":"Outcome of plasmapheresis in myasthenia gravis:Delayed therapy is not favorable","volume":"43","author":"Mandawat","year":"2011","journal-title":"Muscle Nerve"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_110_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:24:51Z","timestamp":1787837091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_110_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_110_22","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"2022-08-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}